Active Pharmaceutical Ingredient (API) Market Report

Global Active Pharmaceutical Ingredient (API) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：166
  • REPORT CODE：GMM847582
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Active Pharmaceutical Ingredient (API) market report explains the definition, types, applications, major countries, and major players of the Active Pharmaceutical Ingredient (API) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Teva

    • Sun Pharmaceutical

    • Aurobindo Pharma

    • Albemarle

    • Sigma-Aldrich

    • Mylan

    • Allergan

    By Type:

    • Innovative APIS Segment

    • Generic APIS Segment

    By End-User:

    • Oncology

    • Diabetes

    • Cardiovascular Disease

    • Cns and Neurological Disorders

    • Orthopedic Disorders

    • Nephrology

    • Ophthalmology

    • Pulmonology

    • Gastrointestinal Disorders

    • Endocrinology

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Active Pharmaceutical Ingredient (API) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Active Pharmaceutical Ingredient (API) Outlook to 2028- Original Forecasts

    • 2.2 Active Pharmaceutical Ingredient (API) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Active Pharmaceutical Ingredient (API) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Active Pharmaceutical Ingredient (API) Market- Recent Developments

    • 6.1 Active Pharmaceutical Ingredient (API) Market News and Developments

    • 6.2 Active Pharmaceutical Ingredient (API) Market Deals Landscape

    7 Active Pharmaceutical Ingredient (API) Raw Materials and Cost Structure Analysis

    • 7.1 Active Pharmaceutical Ingredient (API) Key Raw Materials

    • 7.2 Active Pharmaceutical Ingredient (API) Price Trend of Key Raw Materials

    • 7.3 Active Pharmaceutical Ingredient (API) Key Suppliers of Raw Materials

    • 7.4 Active Pharmaceutical Ingredient (API) Market Concentration Rate of Raw Materials

    • 7.5 Active Pharmaceutical Ingredient (API) Cost Structure Analysis

      • 7.5.1 Active Pharmaceutical Ingredient (API) Raw Materials Analysis

      • 7.5.2 Active Pharmaceutical Ingredient (API) Labor Cost Analysis

      • 7.5.3 Active Pharmaceutical Ingredient (API) Manufacturing Expenses Analysis

    8 Global Active Pharmaceutical Ingredient (API) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Active Pharmaceutical Ingredient (API) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Active Pharmaceutical Ingredient (API) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Active Pharmaceutical Ingredient (API) Market Outlook by Types and Applications to 2022

    • 9.1 Global Active Pharmaceutical Ingredient (API) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Innovative APIS Segment Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Generic APIS Segment Consumption and Growth Rate (2017-2022)

    • 9.2 Global Active Pharmaceutical Ingredient (API) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiovascular Disease Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cns and Neurological Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Orthopedic Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Nephrology Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Ophthalmology Consumption and Growth Rate (2017-2022)

      • 9.2.8 Global Pulmonology Consumption and Growth Rate (2017-2022)

      • 9.2.9 Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.10 Global Endocrinology Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Active Pharmaceutical Ingredient (API) Market Analysis and Outlook till 2022

    • 10.1 Global Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.2.2 Canada Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.2.3 Mexico Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.2 UK Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.3 Spain Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.4 Belgium Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.5 France Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.6 Italy Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.7 Denmark Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.8 Finland Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.9 Norway Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.10 Sweden Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.11 Poland Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.12 Russia Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.3.13 Turkey Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.2 Japan Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.3 India Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.4 South Korea Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.5 Pakistan Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.6 Bangladesh Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.7 Indonesia Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.8 Thailand Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.9 Singapore Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.10 Malaysia Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.11 Philippines Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.4.12 Vietnam Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.5.2 Colombia Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.5.3 Chile Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.5.4 Argentina Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.5.5 Venezuela Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.5.6 Peru Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.5.8 Ecuador Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.6.2 Kuwait Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.6.3 Oman Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.6.4 Qatar Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.7.2 South Africa Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.7.3 Egypt Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.7.4 Algeria Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

      • 10.8.2 New Zealand Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    11 Global Active Pharmaceutical Ingredient (API) Competitive Analysis

    • 11.1 Teva

      • 11.1.1 Teva Company Details

      • 11.1.2 Teva Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Teva Active Pharmaceutical Ingredient (API) Main Business and Markets Served

      • 11.1.4 Teva Active Pharmaceutical Ingredient (API) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sun Pharmaceutical

      • 11.2.1 Sun Pharmaceutical Company Details

      • 11.2.2 Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Main Business and Markets Served

      • 11.2.4 Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Aurobindo Pharma

      • 11.3.1 Aurobindo Pharma Company Details

      • 11.3.2 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Main Business and Markets Served

      • 11.3.4 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Albemarle

      • 11.4.1 Albemarle Company Details

      • 11.4.2 Albemarle Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Albemarle Active Pharmaceutical Ingredient (API) Main Business and Markets Served

      • 11.4.4 Albemarle Active Pharmaceutical Ingredient (API) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Sigma-Aldrich

      • 11.5.1 Sigma-Aldrich Company Details

      • 11.5.2 Sigma-Aldrich Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Sigma-Aldrich Active Pharmaceutical Ingredient (API) Main Business and Markets Served

      • 11.5.4 Sigma-Aldrich Active Pharmaceutical Ingredient (API) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Mylan

      • 11.6.1 Mylan Company Details

      • 11.6.2 Mylan Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Mylan Active Pharmaceutical Ingredient (API) Main Business and Markets Served

      • 11.6.4 Mylan Active Pharmaceutical Ingredient (API) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Allergan

      • 11.7.1 Allergan Company Details

      • 11.7.2 Allergan Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Allergan Active Pharmaceutical Ingredient (API) Main Business and Markets Served

      • 11.7.4 Allergan Active Pharmaceutical Ingredient (API) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Active Pharmaceutical Ingredient (API) Market Outlook by Types and Applications to 2028

    • 12.1 Global Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Innovative APIS Segment Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Generic APIS Segment Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Cns and Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Orthopedic Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Nephrology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.7 Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.8 Global Pulmonology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.9 Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.10 Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Active Pharmaceutical Ingredient (API) Market Analysis and Outlook to 2028

    • 13.1 Global Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.2 UK Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.5 France Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.3 India Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Active Pharmaceutical Ingredient (API)

    • Figure of Active Pharmaceutical Ingredient (API) Picture

    • Table Global Active Pharmaceutical Ingredient (API) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Active Pharmaceutical Ingredient (API) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Innovative APIS Segment Consumption and Growth Rate (2017-2022)

    • Figure Global Generic APIS Segment Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Cns and Neurological Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Orthopedic Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Nephrology Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmology Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmonology Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Endocrinology Consumption and Growth Rate (2017-2022)

    • Figure Global Active Pharmaceutical Ingredient (API) Consumption by Country (2017-2022)

    • Table North America Active Pharmaceutical Ingredient (API) Consumption by Country (2017-2022)

    • Figure United States Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Canada Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Table Europe Active Pharmaceutical Ingredient (API) Consumption by Country (2017-2022)

    • Figure Germany Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure UK Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Spain Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure France Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Italy Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Finland Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Norway Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Poland Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Russia Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Table APAC Active Pharmaceutical Ingredient (API) Consumption by Country (2017-2022)

    • Figure China Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Japan Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure India Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Table South America Active Pharmaceutical Ingredient (API) Consumption by Country (2017-2022)

    • Figure Brazil Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Chile Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Peru Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Table GCC Active Pharmaceutical Ingredient (API) Consumption by Country (2017-2022)

    • Figure Bahrain Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Oman Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Table Africa Active Pharmaceutical Ingredient (API) Consumption by Country (2017-2022)

    • Figure Nigeria Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Table Oceania Active Pharmaceutical Ingredient (API) Consumption by Country (2017-2022)

    • Figure Australia Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Table Teva Company Details

    • Table Teva Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Active Pharmaceutical Ingredient (API) Main Business and Markets Served

    • Table Teva Active Pharmaceutical Ingredient (API) Product Portfolio

    • Table Sun Pharmaceutical Company Details

    • Table Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Main Business and Markets Served

    • Table Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Product Portfolio

    • Table Aurobindo Pharma Company Details

    • Table Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Pharma Active Pharmaceutical Ingredient (API) Main Business and Markets Served

    • Table Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product Portfolio

    • Table Albemarle Company Details

    • Table Albemarle Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Albemarle Active Pharmaceutical Ingredient (API) Main Business and Markets Served

    • Table Albemarle Active Pharmaceutical Ingredient (API) Product Portfolio

    • Table Sigma-Aldrich Company Details

    • Table Sigma-Aldrich Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sigma-Aldrich Active Pharmaceutical Ingredient (API) Main Business and Markets Served

    • Table Sigma-Aldrich Active Pharmaceutical Ingredient (API) Product Portfolio

    • Table Mylan Company Details

    • Table Mylan Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Active Pharmaceutical Ingredient (API) Main Business and Markets Served

    • Table Mylan Active Pharmaceutical Ingredient (API) Product Portfolio

    • Table Allergan Company Details

    • Table Allergan Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Active Pharmaceutical Ingredient (API) Main Business and Markets Served

    • Table Allergan Active Pharmaceutical Ingredient (API) Product Portfolio

    • Figure Global Innovative APIS Segment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic APIS Segment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cns and Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Orthopedic Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nephrology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pulmonology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Active Pharmaceutical Ingredient (API) Consumption Forecast by Country (2022-2028)

    • Table North America Active Pharmaceutical Ingredient (API) Consumption Forecast by Country (2022-2028)

    • Figure United States Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Active Pharmaceutical Ingredient (API) Consumption Forecast by Country (2022-2028)

    • Figure Germany Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Active Pharmaceutical Ingredient (API) Consumption Forecast by Country (2022-2028)

    • Figure China Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Active Pharmaceutical Ingredient (API) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Active Pharmaceutical Ingredient (API) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Active Pharmaceutical Ingredient (API) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Active Pharmaceutical Ingredient (API) Consumption Forecast by Country (2022-2028)

    • Figure Australia Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US